Statements (23)
Predicate | Object |
---|---|
gptkbp:instanceOf |
gptkb:chemical_compound
|
gptkbp:ATCCode |
gptkb:N06AX13
|
gptkbp:CASNumber |
153254-86-1
|
gptkbp:drugClass |
norepinephrine reuptake inhibitor
|
gptkbp:hasBiologicalActivity |
inhibits norepinephrine reuptake
|
gptkbp:hasInChIKey |
QKJXYYOQSYFJNP-UHFFFAOYSA-N
|
gptkbp:hasMolecularFormula |
C17H19NO3
|
gptkbp:hasSMILES |
COC1=CC=CC=C1OCCC(C2=CC=CC=C2)N(C)C
|
gptkbp:hasUNII |
6T6UO8361S
|
https://www.w3.org/2000/01/rdf-schema#label |
CHEMBL14267
|
gptkbp:IUPACName |
gptkb:(RS)-3-(2-methoxyphenoxy)-N-methyl-3-phenylpropan-1-amine
|
gptkbp:molecularWeight |
285.34
|
gptkbp:PubChem_CID |
gptkb:CHEMBL14267
4413 |
gptkbp:routeOfAdministration |
oral
|
gptkbp:status |
investigational
|
gptkbp:synonym |
gptkb:Nisoxetine
gptkb:LY94939 |
gptkbp:target |
gptkb:norepinephrine_transporter
|
gptkbp:therapeuticArea |
gptkb:depression
gptkb:attention_deficit_hyperactivity_disorder |
gptkbp:bfsParent |
gptkb:linalool
|
gptkbp:bfsLayer |
6
|